THE DNA DAMAGE RESPONSE: A KEY FACTOR IN CANCER DEVELOPMENT, PROGRESSION AND TREATMENT

Prof Yossi Shiloh
Tel Aviv University

למצגת PDF

The evolving PARPi Story

ד"ר רינת ברנשטיין מולכו
המכון האונקולוגי – מרכז רפואי שיבא

למצגת PDF

Predicting response to PARPi beyond BRCA: Molecular and clinical biomarkers

Dr. Daliah Tsoref
Rabin Medical Centre; Davidoff Centre

למצגת PDF

PARPi Resistance – Mechanisms, Diagnosis and Solutions

Keren Levanon, MD, PhD
Institute of Oncology, Sheba Medical Center

למצגת PDF

Mirena and Peri‐Menopausal Breast Cancer Risk: Maccabi Experience & the Danish Registry

Dr. Nava Siegelmann Danieli,
Director Oncology Service line, Maccabi health Services

למצגת PDF

Hormone Replacement Therapy in Women With a Personal History of Breast Cancer

Noa Efrat (Ben-Baruch),
Head, Dept of Oncology Kaplan Medical Center

למצגת PDF

Is prophylactic breast surgery essential in BRCA mutation carriers following diagnosis of ovarian cancer?

Prof. Tamar Safra,
Head of Onco-Gynecology Service, Tel Aviv Medical Center

למצגת PDF